Latest The Michael J. Fox Foundation Stories
Baseline paper highlights findings from Fox Trial Finder, first smart-matching clinical research recruitment tool for Parkinson's disease NEW YORK, Feb.
Biotech Startup, Collaborator Receive Parkinson's Disease Grant to Study Newly Identified Pathway, Develop Novel Treatments Lexington, Kentucky (PRWEB) December
Fellowship Program Building a Workforce of Parkinson's Disease Care and Research Specialists NEW YORK, Dec. 2, 2014 /PRNewswire-USNewswire/ -- The Michael J.
- Only 28% of Parkinson's patients are currently receiving care from a Parkinson's specialist NEW YORK, Sept.
NEW YORK, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Research projects from five groups active in Parkinson's research comprise the 2014 first half (1H 2014) of The Michael J.
NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease.
FPRT Bio works closely with academic leaders and research organizations to advance the use of XPro1595 in the treatment of Parkinson’s disease. Dallas, Texas
AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J.
VIENNA, July 29, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.